Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction

Munaza Riaz, Steven M. Smith, Eric Dietrich, David E. Winchester, Jingchuan Guo, Haesuk ParkAmerican 2023 · DOI

Abstract

During the 13-year study period, the utilization of ARNIs, ARBs, ARAs, CCBs, and SGLT2i increased while the utilization of digoxin, nitrates, diuretics, and β-blockers decreased among patients with HFpEF.
BibTeX
@inproceedings{riaz2023trends,
  author = {Munaza Riaz and Steven M. Smith and Eric Dietrich and David E. Winchester and Jingchuan Guo and Haesuk Park},
  title = {{Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction}},
  booktitle = {American},
  year = {2023},
  doi = {10.1016/j.ahjo.2023.100259},
}

Loading related content...

Figure